Publications by authors named "Dane Colead-Bergum"
Article Synopsis
- The study aimed to assess the feasibility and safety of injecting CD34+ stem cells harvested from bone marrow into the eyes of seven patients with vision loss caused by retinitis pigmentosa (RP).
- Researchers conducted a Phase I, open-label trial, where comprehensive eye examinations were performed at multiple time points, and bone marrow was collected for stem cell isolation and injection on the same day.
- Results showed that all CD34+ cells used were viable and safe, with most participants maintaining or improving their visual acuity and field during the 6-month follow-up, despite one case of a minor transient adverse effect.
